Physician
Internal Medicine
Dr. Robert M. Cuddihy, MD
|
|
Give Review
Robert Cuddihy practices Internal Medicine. He graduated from University of Massachusetts Medical School. University of Massachusetts Medical School is ranked 49 in research and 12 in primary care medicine Dr. Robert M. Cuddihy is also a published doctor. He has 32 publication published. The most recent publication is: Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population.
Publications
- The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy.
- Considerations for Diabetes: Treatment With Insulin Pen Devices.
- Improving blood pressure control in individuals with diabetes: a quality improvement collaborative.
- Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey.
- Continuous glucose monitoring reveals different glycemic responses of moderate- vs high-carbohydrate lunch meals in people with type 2 diabetes.
- Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes.
- Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.
- Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics.
- Women with diabetes have poorer control of blood pressure than men.
- One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metfor...
- Performance evaluation and labeling comprehension of a new blood glucose monitoring system with integrated information management.
- Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, ope...
- 2nd Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 7-10, 2009, Berlin, Germany.
- Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes:...
- Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin.
- A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized nonin...
- Exenatide once-weekly clinical development: safety and efficacy across a range of background therapies.
- A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controll...
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
- Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.
- Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis.
- Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial.
- Screening mammogram utilization in women with diabetes.
- Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population.
- Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease.
- Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease.
- A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females.
- Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptor.
- The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiolog...
- In support of an early polypharmacy approach to the treatment of type 2 diabetes.
- Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-...
Schools
University Of Massachusetts Medical School
Maine Med Center
Mayo Clinic Rochester
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Maine Medical Center -
University of Massachusetts Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Holly B. Gustafson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah Mangham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ariel R. Centurion, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol A. Manning, MD |
|
|
Dr. Emily C. Rose, MD |
|
|
Dr. Shabnam Lankarani, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor C. Van Hee, MD |
|
|
Dr. Sue A. Ravenscraft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony C. Woolley, MD
This Doctor is OpenDoctor Recommended.
|